Li Z - Search Results

1

Janus kinases (JAKs): The efficient therapeutic targets for autoimmune diseases and myeloproliferative disorders.

Xu P, Shen P, Yu B, Xu X, Ge R, Cheng X, Chen Q, Bian J, Li Z, Wang J. Xu P, et al. Among authors: li z. Eur J Med Chem. 2020 Apr 15;192:112155. doi: 10.1016/j.ejmech.2020.112155. Epub 2020 Feb 18. Eur J Med Chem. 2020. PMID: 32120325 Review.

2

Recent progress of SRC family kinase inhibitors as anticancer agents.

Cao X, You QD, Li ZY, Wang XJ, Lu XY, Liu XR, Xu D, Liu B. Cao X, et al. Mini Rev Med Chem. 2008 Sep;8(10):1053-63. doi: 10.2174/138955708785740634. Mini Rev Med Chem. 2008. PMID: 18782057 Review.

3

Discovery of a novel series of quinolone and naphthyridine derivatives as potential topoisomerase I inhibitors by scaffold modification.

You QD, Li ZY, Huang CH, Yang Q, Wang XJ, Guo QL, Chen XG, He XG, Li TK, Chern JW. You QD, et al. J Med Chem. 2009 Sep 24;52(18):5649-61. doi: 10.1021/jm900469e. J Med Chem. 2009. PMID: 19715319

4

Synthesis and biological evaluations of novel indenoisoquinolines as topoisomerase I inhibitors.

Zhang X, Wang R, Zhao L, Lu N, Wang J, You Q, Li Z, Guo Q. Zhang X, et al. Among authors: li z. Bioorg Med Chem Lett. 2012 Jan 15;22(2):1276-81. doi: 10.1016/j.bmcl.2011.10.019. Epub 2011 Oct 24. Bioorg Med Chem Lett. 2012. PMID: 22079759

5

Synthesis and biological evaluation of 7-O-modified oroxylin A derivatives.

Fu W, Wang J, Yu L, Zhao L, Lu N, You Q, Guo Q, Li Z. Fu W, et al. Among authors: li z. Bioorg Med Chem Lett. 2012 Jan 15;22(2):1118-21. doi: 10.1016/j.bmcl.2011.11.117. Epub 2011 Dec 6. Bioorg Med Chem Lett. 2012. PMID: 22196122

6

Synthesis and biological evaluation of baicalein derivatives as potent antitumor agents.

Luo R, Wang J, Zhao L, Lu N, You Q, Guo Q, Li Z. Luo R, et al. Among authors: li z. Bioorg Med Chem Lett. 2014 Mar 1;24(5):1334-8. doi: 10.1016/j.bmcl.2014.01.053. Epub 2014 Jan 27. Bioorg Med Chem Lett. 2014. PMID: 24507925

7

Recent androgen receptor antagonists in prostate cancer.

Lu X, Dun K, Wang Y, Yang Y, You Q, Li Z. Lu X, et al. Among authors: li z. Mini Rev Med Chem. 2014;14(8):655-63. doi: 10.2174/1389557514666140622203207. Mini Rev Med Chem. 2014. PMID: 24958215 Review.

8

Research progress of indoleamine 2,3-dioxygenase inhibitors.

Jiang T, Sun Y, Yin Z, Feng S, Sun L, Li Z. Jiang T, et al. Among authors: li z. Future Med Chem. 2015;7(2):185-201. doi: 10.4155/fmc.14.151. Future Med Chem. 2015. PMID: 25686005 Review.

9

Progress in the research of GPIIb/IIIa antagonists.

Xie Z, Cao C, Feng S, Huang J, Li Z. Xie Z, et al. Among authors: li z. Future Med Chem. 2015;7(9):1149-71. doi: 10.4155/fmc.15.53. Future Med Chem. 2015. PMID: 26132524 Review.

10

Design, synthesis of novel tryptophan derivatives for antiplatelet aggregation activity based on tripeptide pENW (pGlu-Asn-Trp).

Xie Z, Feng S, Wang Y, Cao C, Huang J, Chen Y, Kong Y, Li Z. Xie Z, et al. Among authors: li z. Eur J Med Chem. 2015 Sep 18;102:363-74. doi: 10.1016/j.ejmech.2015.07.016. Epub 2015 Jul 10. Eur J Med Chem. 2015. PMID: 26298494

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

103,506 results

Search Page